viewVentriPoint Diagnostics Ltd.

VentriPoint Diagnostics to advance AI capabilities in its heart device with new gov't funding

The firm is set to partner Ryerson University on the project

Ventripoint is partnering with Ryerson University

Medical imaging firm VentriPoint Diagnostics Ltd (CVE:VPT) revealed its technology has been further boosted by a government grant.

The firm is set to partner Ryerson University on a project to further advance the Al (artificial intelligence) capabilities already imbedded in the heart monitoring VMS+ products after the company revealed it is taking part in a Natural Sciences and Engineering Research Council (NSERC) Engage grant.

"This is very exciting for Ventripoint and the healthcare community at large because it allows us to bring new technology to market that will ultimately improve clinical outcomes and reduce overall cost of care," said Desmond Hirson, president of Ventripoint.

The progress is in keeping with Ventripoint's  mission of being a leader in providing medical products that use AI to enhance the productivity, accuracy and consistency of cardiac measurements, it said.

"The benefits of this technology can also be extended to other modalities and imaging technologies, such as MRI and CT, to further expand the use of AI in the field of Medical Imaging."

The firm says its VMS+ device is the first cost-effective and accurate AI tool for measuring whole heart function using conventional ultrasound.

VentriPoint shares added 1.64% to C$0.31.

Quick facts: VentriPoint Diagnostics Ltd.

Price: 0.075 CAD

Market: TSX-V
Market Cap: $5.15 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Buds & Duds: Ontario's cannabis retail expansion plan gives cannabis stocks...

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, was 1.4% higher at 116.7 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF jumped 2.4% at C$9.55, while the OTCQX Cannabis index gained 0.6% to 434 points. Buds today are The Green...

2 days, 9 hours ago

2 min read